Home › Biotech ETFs: 3 Questions For IShares Investing Expert
 

Keywords :   


Biotech ETFs: 3 Questions For IShares Investing Expert

2015-07-23 06:55:09| Biotech - Topix.net

TF investors in biotechnology stocks may be rattled by the nose-dive of the first heavyweight out of the earnings gate. , the $10 billion biotech exchange traded fund, has lost 0.8% in the past three trading sessions as 's reports this week, IBD spoke to Tushar Yadava, an iShares investment strategist, on whether the biotech sector has room to run: Tushar Yadava: Biotech investors entering for the first time are likely doing so in search of consistent growth - something the sector has delivered for a few years running.

Tags: questions expert investing biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 26
05.07Hurricane Beryl Wind Speed Probabilities Number 26
05.07Hurricane Beryl Forecast Advisory Number 26
05.07Hurricane Beryl Public Advisory Number 26
05.07Tropical Storm Aletta Graphics
05.07Tropical Storm Aletta Wind Speed Probabilities Number 3
05.07Summary for Tropical Storm Aletta (EP1/EP012024)
More »